OP9-DL1 T cell immunotherapy acute myeloid leukemia (AML) common gamma chain cytokines hematopoietic stem cells

Journal

Oncoimmunology
ISSN: 2162-402X
Titre abrégé: Oncoimmunology
Pays: United States
ID NLM: 101570526

Informations de publication

Date de publication:
2021
Historique:
entrez: 9 8 2021
pubmed: 10 8 2021
medline: 16 10 2021
Statut: epublish

Résumé

T cell receptor (TCR)-redirected T cells target intracellular antigens such as Wilms' tumor 1 (WT1), a tumor-associated antigen overexpressed in several malignancies, including acute myeloid leukemia (AML). For both chimeric antigen receptor (CAR)- and TCR-redirected T cells, several clinical studies indicate that T cell subsets with a less-differentiated phenotype (e.g. stem cell memory T cells, T

Identifiants

pubmed: 34367734
doi: 10.1080/2162402X.2021.1954800
pii: 1954800
pmc: PMC8312599
doi:

Substances chimiques

Antigens, Neoplasm 0
Interleukins 0
interleukin-21 MKM3CA6LT1

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1954800

Informations de copyright

© 2021 The Author(s). Published with license by Taylor & Francis Group, LLC.

Déclaration de conflit d'intérêts

The authors declare no conflict of interest.

Références

Nature. 2006 Feb 9;439(7077):682-7
pubmed: 16382236
J Immunother. 2005 May-Jun;28(3):258-67
pubmed: 15838383
Cancer Res. 2007 Mar 15;67(6):2425-9
pubmed: 17363559
Leukemia. 2014 Apr;28(4):830-41
pubmed: 24091848
Cell Rep. 2018 Mar 20;22(12):3175-3190
pubmed: 29562175
Nat Commun. 2021 Feb 11;12(1):951
pubmed: 33574265
Cancer Immunol Immunother. 2010 Jun;59(6):921-31
pubmed: 20101507
Blood. 2008 Jun 1;111(11):5326-33
pubmed: 18276844
J Exp Med. 2005 Jan 3;201(1):139-48
pubmed: 15630141
Oncoimmunology. 2020 Feb 17;9(1):1727078
pubmed: 32117593
J Immunother. 2018 Jul/Aug;41(6):274-283
pubmed: 29864078
Proc Natl Acad Sci U S A. 2005 Jul 5;102(27):9571-6
pubmed: 15980149
J Clin Invest. 2005 Jun;115(6):1616-26
pubmed: 15931392
J Transl Med. 2016 Jul 19;14(1):214
pubmed: 27435312
Science. 2002 Oct 25;298(5594):850-4
pubmed: 12242449
Proc Natl Acad Sci U S A. 2010 Jun 15;107(24):10972-7
pubmed: 20534461
Sci Immunol. 2017 Feb 24;2(8):
pubmed: 28783686
Cancer Res. 2015 Dec 15;75(24):5187-5193
pubmed: 26627006
Nature. 2017 Jul 6;547(7661):104-108
pubmed: 28658204
J Immunol. 2004 Dec 15;173(12):7125-30
pubmed: 15585832
Blood. 2007 May 15;109(10):4135-42
pubmed: 17234735
Nat Med. 2017 Jan 6;23(1):18-27
pubmed: 28060797
Blood. 2005 Oct 15;106(8):2693-9
pubmed: 15976178
Leukemia. 2003 Jul;17(7):1301-12
pubmed: 12835718
Blood. 2016 Jul 28;128(4):519-28
pubmed: 27226436
Haematologica. 2020 May;105(5):1306-1316
pubmed: 31371409
J Immunol. 2005 Nov 15;175(10):7046-52
pubmed: 16272366
Cancer Immunol Immunother. 2011 Feb;60(2):173-86
pubmed: 20972785
Nat Med. 2019 Jul;25(7):1064-1072
pubmed: 31235963
Nat Methods. 2017 May;14(5):521-530
pubmed: 28369043
Blood. 2013 Jan 24;121(4):573-84
pubmed: 23160470
Front Immunol. 2019 Feb 20;10:263
pubmed: 30842774
Exp Cell Res. 2011 Mar 10;317(5):620-31
pubmed: 21376175
Immunity. 2009 Nov 20;31(5):834-44
pubmed: 19879163
J Clin Invest. 2008 Jan;118(1):294-305
pubmed: 18060041
N Engl J Med. 2019 Jan 3;380(1):45-56
pubmed: 30501490
Blood. 2004 Apr 15;103(8):3065-72
pubmed: 15070686
Curr Opin Immunol. 2005 Apr;17(2):195-201
pubmed: 15766681
Sci Transl Med. 2013 Feb 27;5(174):174ra27
pubmed: 23447018
Nat Med. 2011 Sep 18;17(10):1290-7
pubmed: 21926977
Proc Natl Acad Sci U S A. 2004 Feb 17;101(7):1969-74
pubmed: 14762166
Nat Med. 2010 May;16(5):565-70, 1p following 570
pubmed: 20400962
Eur J Immunol. 2013 Nov;43(11):2797-809
pubmed: 24258910
Nat Med. 2002 Apr;8(4):379-85
pubmed: 11927944
J Biomed Mater Res A. 2006 Dec 1;79(3):689-97
pubmed: 16845670
Annu Rev Med. 2013;64:71-90
pubmed: 23092383
Clin Cancer Res. 2011 Jul 1;17(13):4550-7
pubmed: 21498393
Oncoimmunology. 2017 Jan 19;6(3):e1283460
pubmed: 28405508
Immunity. 2010 Jul 23;33(1):128-40
pubmed: 20619696
Blood. 2003 Mar 1;101(5):1784-9
pubmed: 12411302
Stem Cells. 2014 Jan;32(1):93-104
pubmed: 23939944
Cancer Res. 2011 May 15;71(10):3516-27
pubmed: 21558388
Science. 2006 Oct 6;314(5796):126-9
pubmed: 16946036
Int J Mol Sci. 2020 Nov 20;21(22):
pubmed: 33233766

Auteurs

Sarah Bonte (S)

Department of Internal Medicine and Pediatrics, Ghent University, Ghent, Belgium.
Cancer Research Institute Ghent (CRIG), Ghent, Belgium.

Stijn de Munter (S)

Cancer Research Institute Ghent (CRIG), Ghent, Belgium.
Department of Diagnostic Sciences, Ghent University, Ghent, Belgium.

Lore Billiet (L)

Department of Diagnostic Sciences, Ghent University, Ghent, Belgium.

Glenn Goetgeluk (G)

Cancer Research Institute Ghent (CRIG), Ghent, Belgium.
Department of Diagnostic Sciences, Ghent University, Ghent, Belgium.

Joline Ingels (J)

Department of Diagnostic Sciences, Ghent University, Ghent, Belgium.

Hanne Jansen (H)

Department of Diagnostic Sciences, Ghent University, Ghent, Belgium.

Melissa Pille (M)

Department of Diagnostic Sciences, Ghent University, Ghent, Belgium.

Laurenz de Cock (L)

Cancer Research Institute Ghent (CRIG), Ghent, Belgium.
Department of Biomolecular Medicine, Ghent University, Ghent, Belgium.

Karin Weening (K)

Department of Diagnostic Sciences, Ghent University, Ghent, Belgium.

Tom Taghon (T)

Cancer Research Institute Ghent (CRIG), Ghent, Belgium.
Department of Diagnostic Sciences, Ghent University, Ghent, Belgium.

Georges Leclercq (G)

Cancer Research Institute Ghent (CRIG), Ghent, Belgium.
Department of Diagnostic Sciences, Ghent University, Ghent, Belgium.

Bart Vandekerckhove (B)

Cancer Research Institute Ghent (CRIG), Ghent, Belgium.
Department of Diagnostic Sciences, Ghent University, Ghent, Belgium.

Tessa Kerre (T)

Department of Internal Medicine and Pediatrics, Ghent University, Ghent, Belgium.
Cancer Research Institute Ghent (CRIG), Ghent, Belgium.
Department of Diagnostic Sciences, Ghent University, Ghent, Belgium.
Department of Hematology, Ghent University Hospital, Ghent, Belgium.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH